Clinical trial

Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

NCT03933696

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-01-02

PhaseNA

Study timeline

Study start (actual)2019-01-02Date precision: day

Registry last updated2026-07-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Cognitive Impairmentunresolved

Alzheimer Diseaseunresolved

Type2 Diabetesunresolved

Interventions

Tailored Lighting InterventionDEVICE

Sponsors & collaborators

Icahn School of Medicine at Mount Sinailead sponsor

Mapped research locations

New YorkNew York, United States1 New BrunswickNew Jersey, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03933696 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.